» Articles » PMID: 31329813

Symbol Digit Modalities Test: Regression-Based Normative Data and Clinical Utility

Overview
Specialties Neurology
Psychology
Date 2019 Jul 23
PMID 31329813
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to provide regression-based normative data for the written, oral, and incidental recall trials of the Symbol Digit Modalities Test (SDMT).

Method: Regression-based normative equations for the written and oral trials were derived from 536 healthy men and women between the ages of 18 and 91. Normative equations for the incidental recall trial are provided for a subset of the normative sample (age range = 60-91). The clinical utility of the newly developed norms was examined by comparing mean performance and rates of impaired scores for participants with traumatic brain injury (TBI), mild cognitive impairment (MCI), and dementia. Within-group analyses were used to compare the new norms to the original published norms.

Results: Age, education, and sex were all significant predictors of written trial performance, age and education were significant predictors of oral trial performance, and only age predicted incidental recall trial performance. As expected, the TBI group demonstrated the highest rates of impaired performance on both written and oral trials. Participants with dementia showed the highest rate of impaired scores on the incidental recall trial, followed by participants with amnestic MCI. Compared to traditional norming methods, the regression-based norms classified more clinical participants as impaired on both the written and oral trials.

Conclusions: Comprehensive regression-based normative equations with demonstrated clinical utility are provided to improve the detection of cerebral dysfunction using the SDMT. A calculator with the normative equations is provided so that raw scores can be easily converted to demographically-corrected standardized scores.

Citing Articles

Alzheimer's disease with depression: clinical characteristics and potential mechanisms involving orexin and brain atrophy.

Li J, Lian T, Li J, Wei N, Guo P, He M Transl Psychiatry. 2025; 15(1):66.

PMID: 39994172 PMC: 11850912. DOI: 10.1038/s41398-025-03251-4.


Non-Invasive Diagnosis of Moyamoya Disease Using Serum Metabolic Fingerprints and Machine Learning.

Weng R, Xu Y, Gao X, Cao L, Su J, Yang H Adv Sci (Weinh). 2024; 12(8):e2405580.

PMID: 39737836 PMC: 11848555. DOI: 10.1002/advs.202405580.


Abnormal eye movements: relationship with clinical symptoms and predictive value for Alzheimer's disease.

Qi J, Lian T, Guo P, He M, Li J, Li J Front Aging Neurosci. 2024; 16:1471698.

PMID: 39640423 PMC: 11617582. DOI: 10.3389/fnagi.2024.1471698.


The cerebellar glucose metabolism in moyamoya vasculopathy and its correlation with neurocognitive performance after cerebral revascularization surgery: a [F]FDG PET study.

Weng R, Ren S, Su J, Jiang H, Yang H, Gao X Eur J Nucl Med Mol Imaging. 2024; 52(4):1520-1534.

PMID: 39638951 PMC: 11839855. DOI: 10.1007/s00259-024-06995-1.


Prevalence of Mild and Severe Cognitive Impairment in World Trade Center Exposed Fire Department of the City of New York (FDNY) and General Emergency Responders.

Mann F, Mueller A, Zeig-Owens R, Choi J, Prezant D, Carr M medRxiv. 2024; .

PMID: 39148853 PMC: 11326356. DOI: 10.1101/2024.08.04.24311457.